Certified by Founder Lodge
Gate Bioscience
United States - Brisbane, CA, California
START UP
1 Disclosed Funding Rounds $60,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Gate Bioscience is a preclinical biotechnology company creating a new class of medicines called Molecular Gates. Molecular Gates are small molecule drugs that selectively eliminate harmful ex
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 02 ,2023 | Series A | $60,000,000 | |
| November, 14 ,2025 | Series B | $65,000,000 |
ARCH Venture Partners
a16z Bio + Health
Versant Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Rork | $15,000,000 | (Apr 10, 2026)
Plume (YC S24) | $3,900,000 | (Apr 10, 2026)
Haast | $12,000,000 | (Apr 10, 2026)
CareGlance Srl | $4,092,182 | (Apr 10, 2026)
Sigma Automate | $2,750,000 | (Apr 10, 2026)
